Private equity firm Kainos Capital announced the closing of its Kainos Capital Partners Fund III, with over $1 billion in capital commitments.
Kainos aims to build strategically relevant food and consumer companies by implementing initiatives and leveraging its industry experience and relationships to help partner businesses capitalise on growth opportunities, improving profitability.
The fund will primarily target family-owned businesses and corporate carve-outs in the food and consumer products sectors with at least $10 million EBITDA.
According to the company, “Fund III can commit in excess of $300 million of equity, and potentially more with our Limited Partner co-investment programme, in any single transaction”.
Andrew Rosen, managing partner of Kainos, said: “Our bench of seasoned investors and operators within the food and consumer sectors helps drive financial and operational performance by working hand-in-glove with management teams”.
He continued: “We believe Kainos’ sector experience, industry relationships, and robust operating capabilities make us an attractive partner to families and entrepreneurs who are excited about their business’ prospects yet seek to diversify their wealth.
“We are grateful for the strong support we received from our investors, whose continued partnership is a testament to the strength of our team and our Change Capital investment approach.”
Currently, Fund III is approximately one-third invested across three platform acquisitions: CellCore Biosciences, a wellness company that provides dietary supplements that are primarily sold through the practitioner channel; Specialty Sales, a speciality dairy cow health distribution business; and Evriholder Products, a provider of impulse products and merchandising solutions for retailers.
© FoodBev Media Ltd 2024
